The Farnesoid X Receptor as a Master Regulator of Hepatotoxicity

被引:12
|
作者
Rausch, Magdalena [1 ]
Samodelov, Sophia L. [1 ]
Visentin, Michele [1 ]
Kullak-Ublick, Gerd A. [1 ]
机构
[1] Univ Zurich, Univ Hosp Zurich, Dept Clin Pharmacol & Toxicol, CH-8006 Zurich, Switzerland
基金
瑞士国家科学基金会;
关键词
drug-induced liver injury; farnesoid X receptor (FXR); hepatotoxicity; inflammation; liver; NAFLD and NASH; SALT EXPORT PUMP; MULTIDRUG-RESISTANCE PROTEIN-3; INDUCED HEPATIC STEATOSIS; BILE-ACID SYNTHESIS; NUCLEAR RECEPTOR; FATTY LIVER; OBETICHOLIC ACID; UP-REGULATION; NONALCOHOLIC STEATOHEPATITIS; TRANSCRIPTIONAL REGULATION;
D O I
10.3390/ijms232213967
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The nuclear receptor farnesoid X receptor (FXR, NR1H4) is a bile acid (BA) sensor that links the enterohepatic circuit that regulates BA metabolism and elimination to systemic lipid homeostasis. Furthermore, FXR represents a real guardian of the hepatic function, preserving, in a multifactorial fashion, the integrity and function of hepatocytes from chronic and acute insults. This review summarizes how FXR modulates the expression of pathway-specific as well as polyspecific transporters and enzymes, thereby acting at the interface of BA, lipid and drug metabolism, and influencing the onset and progression of hepatotoxicity of varying etiopathogeneses. Furthermore, this review article provides an overview of the advances and the clinical development of FXR agonists in the treatment of liver diseases.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis
    Jiao, Yang
    Lu, Yan
    Li, Xiao-ying
    ACTA PHARMACOLOGICA SINICA, 2015, 36 (01) : 44 - 50
  • [2] Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis
    Yang Jiao
    Yan Lu
    Xiao-ying Li
    Acta Pharmacologica Sinica, 2015, 36 : 44 - 50
  • [3] Farnesoid X Receptor as Target for Therapies to Treat Cholestasis-Induced Liver Injury
    Petrescu, Anca D.
    DeMorrow, Sharon
    CELLS, 2021, 10 (08)
  • [4] The pathophysiological function of non-gastrointestinal farnesoid X receptor
    Yan, Nana
    Yan, Tingting
    Xia, Yangliu
    Hao, Haiping
    Wang, Guangji
    Gonzalez, Frank J.
    PHARMACOLOGY & THERAPEUTICS, 2021, 226
  • [5] Farnesoid X receptor as a regulator of fuel consumption and mitochondrial function
    Han, Chang Yeob
    Kim, Tae Hyun
    Koo, Ja Hyun
    Kim, Sang Geon
    ARCHIVES OF PHARMACAL RESEARCH, 2016, 39 (08) : 1062 - 1074
  • [6] Farnesoid X Receptor-Mediated Bile Acids Regulation in Cholestasis
    Mohammed, Thamer Abdulla
    Zalzala, Munaf H.
    INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2024,
  • [7] Farnesoid X Receptor Agonists: A Promising Therapeutic Strategy for Gastrointestinal Diseases
    Almeqdadi, Mohammad
    Gordon, Fredric D.
    GASTRO HEP ADVANCES, 2024, 3 (03): : 344 - 352
  • [8] Identification and characterization of novel splice variants of human farnesoid X receptor
    Mustonen, Enni-Kaisa
    Lee, Serene M. L.
    Niess, Hanno
    Schwab, Matthias
    Pantsar, Tatu
    Burk, Oliver
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2021, 705
  • [9] Suppressed farnesoid X receptor by iron overload in mice and humans potentiates iron-induced hepatotoxicity
    Xiong, Hui
    Zhang, Chunze
    Han, Lifeng
    Xu, Tong
    Saeed, Khawar
    Han, Jing
    Liu, Jing
    Klaassen, Curtis D.
    Gonzalez, Frank J.
    Lu, Yuanfu
    Zhang, Youcai
    HEPATOLOGY, 2022, 76 (02) : 387 - 403
  • [10] Farnesoid X receptor agonists in biliary tract disease
    Fiorucci, Stefano
    Baldelli, Franco
    CURRENT OPINION IN GASTROENTEROLOGY, 2009, 25 (03) : 252 - 259